Orchid Pharma share price
You have to be logged in to add this to Watchlist.Orchid Pharma is trading 3.37% upper at Rs 1,508.25 as compared to its last closing price. Orchid Pharma has been trading in the price range of 1,522.40 & 1,449.85. Orchid Pharma has given 104.68% in this year & 0.49% in the last 5 days.
Orchid Pharma has TTM P/E ratio 57.09 as compared to the sector P/E of 33.29.There are 3 analysts who have initiated coverage on Orchid Pharma. There are 2 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 27.24 Crores in its last quarter.
Listed peers of Orchid Pharma include Procter & Gamble Health (0.95%), FDC (1.28%), Orchid Pharma (3.37%) etc.
Orchid Pharma has a 30.16% public holding.The Mutual Fund holding in Orchid Pharma was at 16.78% in 30 Sep 2024. The MF holding has decreased from the last quarter. The FII holding in Orchid Pharma was at 1.94% in 30 Sep 2024. The FII holding has increased from the last quarter.
Orchid Pharma share price range
|
| ||||
|
| ||||
Orchid Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 7,396.62 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Orchid Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 11-Nov-24 | Quarterly Results |
| 12-Aug-24 | Quarterly Results |
| 23-May-24 | Audited Results |
| 08-Feb-24 | Quarterly Results |
| 04-Nov-23 | Quarterly Results |
| 10-Aug-23 | Quarterly Results |
| 10-May-23 | Audited Results |
| 09-Feb-23 | Quarterly Results |
| 01-Dec-22 | Others |
| 14-Nov-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 21-Aug-24 | 24-Jul-24 | AGM |
| 29-Nov-23 | 23-Oct-23 | POM |
| 09-Aug-23 | 13-Jul-23 | AGM |
| 15-Jul-22 | 22-Jun-22 | AGM |
| 13-Aug-21 | 23-Jul-21 | AGM |
| 29-Jun-21 | 07-Jun-21 | EGM |
FAQs about Orchid Pharma share price
Orchid Pharma is trading at 1508.25 as on Mon Nov 25 2024 10:25:26. This is 3.37% upper as compared to its previous closing price of 1459.10.
The market capitalization of Orchid Pharma is 7396.62 Cr as on Mon Nov 25 2024 10:25:26.
The average broker rating on Orchid Pharma is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Orchid Pharma is 1591.55 whereas the 52 wk low is 529.95
Orchid Pharma can be analyzed on the following key metrics -
- TTM P/E: 57.09
- Sector P/E: 33.29
- Dividend Yield: 0.00%
- D/E ratio: 0.13
Orchid Pharma reported a net profit of 92.17 Cr in 2024.
Orchid Pharma Quick Links
Orchid Pharma Dividend Orchid Pharma Bonus Orchid Pharma News Orchid Pharma AGM Orchid Pharma Rights Orchid Pharma Splits Orchid Pharma Board Meetings Orchid Pharma Key Metrics Orchid Pharma Shareholdings Orchid Pharma Profit Loss Orchid Pharma Balance Sheet Orchid Pharma Cashflow Orchid Pharma Q1 Results Orchid Pharma Q2 Results Orchid Pharma Q3 Results Orchid Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks